BACKGROUND: The safety of laparoscopic bariatric procedures in superobese patients is still debatable. METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program's participant-use file, the patients who had undergone laparoscopic Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding for morbid obesity were identified. Several perioperative variables, including 30-day morbidity and mortality, were collected, and the data were compared within each procedure after dividing the patients according to the body mass index: <50 kg/m(2) (morbidly obese group and ≥50 kg/m(2) (superobese group). RESULTS: A total of 29,323 patients who had undergone laparoscopic bariatric procedures from 2005 to 2008 were identified. Overall, compared with the morbidly obese group, the superobese group had more men (3:2), younger patients, a greater incidence of co-morbidities (e.g., hypertension and dyspnea), a significantly increased length of stay, and a greater rate of 30-day mortality (.26% versus .07%, odds ratio [OR] 4.38, P = .0001). In the gastric bypass group, the superobese group had a significantly greater incidence of postoperative complications, including superficial wound infections (2.45%, OR 1.68, P = .0001), reintubation (.61%, OR 1.97, P = .003), pulmonary embolism (.30%, OR 2.13, P = .032), myocardial infarction (.07%, P = .017), deep vein thrombosis (.49%, OR 2.06, P = .006), septic shock (.44%, OR 1.74, P = .04), and 30-day mortality (.28%, OR 2.26, P = .026). In the laparoscopic adjustable gastric banding group, the superobese group had a significantly greater incidence of postoperative complications, including superficial (1.65%, OR 2.18, P = .0013) and deep (.23%, OR 2.56, P = .035) wound infections, sepsis, septic shock and 30-day mortality (.17%, OR 13.4, P = .0219). CONCLUSION: Laparoscopic bariatric procedures in superobese patients have been associated with significantly increased complications, including 30-day mortality, compared with morbidly obese patients. However, overall, the procedures appear to be safe, with low complication and 30-day mortality rates.
BACKGROUND: The safety of laparoscopic bariatric procedures in superobese patients is still debatable. METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program's participant-use file, the patients who had undergone laparoscopic Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding for morbid obesity were identified. Several perioperative variables, including 30-day morbidity and mortality, were collected, and the data were compared within each procedure after dividing the patients according to the body mass index: <50 kg/m(2) (morbidly obese group and ≥50 kg/m(2) (superobese group). RESULTS: A total of 29,323 patients who had undergone laparoscopic bariatric procedures from 2005 to 2008 were identified. Overall, compared with the morbidly obese group, the superobese group had more men (3:2), younger patients, a greater incidence of co-morbidities (e.g., hypertension and dyspnea), a significantly increased length of stay, and a greater rate of 30-day mortality (.26% versus .07%, odds ratio [OR] 4.38, P = .0001). In the gastric bypass group, the superobese group had a significantly greater incidence of postoperative complications, including superficial wound infections (2.45%, OR 1.68, P = .0001), reintubation (.61%, OR 1.97, P = .003), pulmonary embolism (.30%, OR 2.13, P = .032), myocardial infarction (.07%, P = .017), deep vein thrombosis (.49%, OR 2.06, P = .006), septic shock (.44%, OR 1.74, P = .04), and 30-day mortality (.28%, OR 2.26, P = .026). In the laparoscopic adjustable gastric banding group, the superobese group had a significantly greater incidence of postoperative complications, including superficial (1.65%, OR 2.18, P = .0013) and deep (.23%, OR 2.56, P = .035) wound infections, sepsis, septic shock and 30-day mortality (.17%, OR 13.4, P = .0219). CONCLUSION: Laparoscopic bariatric procedures in superobese patients have been associated with significantly increased complications, including 30-day mortality, compared with morbidly obese patients. However, overall, the procedures appear to be safe, with low complication and 30-day mortality rates.
Authors: Daniel P Lemanu; Sanket Srinivasa; Primal P Singh; Sharon Johannsen; Andrew D MacCormick; Andrew G Hill Journal: Obes Surg Date: 2012-06 Impact factor: 4.129
Authors: Anna Duprée; Alexander Tarek El Gammal; Stefan Wolter; Silvana Urbanek; Nina Sauer; Oliver Mann; Philipp Busch Journal: Obes Surg Date: 2018-07 Impact factor: 4.129
Authors: Andrea Balla; Gabriela Batista Rodríguez; Santiago Corradetti; Carmen Balagué; Sonia Fernández-Ananín; Eduard M Targarona Journal: Langenbecks Arch Surg Date: 2017-08-05 Impact factor: 3.445
Authors: Nicolas C Buchs; François Pugin; Gilles Chassot; Francesco Volonte; Pascale Koutny-Fong; Monika E Hagen; Philippe Morel Journal: Obes Surg Date: 2013-03 Impact factor: 4.129
Authors: Aliu Sanni; Sebastian Perez; Rachel Medbery; Hernan D Urrego; Craig McCready; Juan P Toro; Ankit D Patel; Edward Lin; John F Sweeney; S Scott Davis Journal: Surg Endosc Date: 2014-08-13 Impact factor: 4.584
Authors: Hassan Nasser; Tommy Ivanics; Oliver A Varban; Jonathan F Finks; Aaron Bonham; Amir A Ghaferi; Arthur M Carlin Journal: Surg Endosc Date: 2020-06-22 Impact factor: 4.584
Authors: Kalyana Nandipati; Edward Lin; Farah Husain; Sebastian Perez; Jahnavi Srinivasan; John F Sweeney; S Scott Davis Journal: Surg Endosc Date: 2012-10-18 Impact factor: 4.584